secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001558370-23-010423
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Received Nasdaq letter on May 24, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price was at least $1.00 for ten consecutive business days (May 10–May 23, 2023).
- Closes the deficiency notice initially received on November 1, 2022 regarding bid price non-compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023010423/0001558370-23-010423-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023010423/tmb-20230524x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-010423

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer